CoChat

Influence of obesity on breast cancer receptor status and prognosis

Rose, David P, Vona-Davis, Linda · 2009 · Expert Review of Anticancer Therapy
Cited by 71

The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.

Abstract

Pre-existing obesity and postoperative weight gain are related to a poor prognosis in breast cancer regardless of menopausal status. Delayed diagnosis may be one cause, but of more biological significance, especially in younger women, is the association of adiposity with estrogen receptor-negative tumors with a propensity for distant metastasis. After the menopause, the major mechanism for the relationship is the elevated estrogen synthesis by adipose tissue; these hormone-dependent tumors are estrogen receptor-positive. Insulin and some adipokines also stimulate breast cancer growth and metastasis, both directly and most probably by enhanced angiogenesis. Weight control is important, not only to target breast cancer progression, but also to reduce the risk of nonbreast cancer mortality risk associated with excess adiposity.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1586/era.09.71

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 3 references

Research works printed but not linked: 68

  1. Bianchini, 2002, Lancet Oncol., 3, 565, 10.1016/S1470-2045(02)00849-5 · DOI · Paper page
  2. Vona-Davis, 2007, Obes. Rev., 8, 395, 10.1111/j.1467-789X.2007.00396.x · DOI · Paper page
  3. 10.1207/S15327914NC4501_1 · DOI · Paper page
  4. Bentzon, 2008, Int. J. Cancer, 122, 1089, 10.1002/ijc.22892 · DOI · Paper page
  5. Bauer, 2007, Cancer, 109, 1721, 10.1002/cncr.22618 · DOI · Paper page
  6. Vona-Davis, 2008, Cancer Epidemiol. Biomarkers Prev., 17, 3319, 10.1158/1055-9965.EPI-08-0544 · DOI
  7. Chang, 2008, Obesity (Silver Spring), 16, 1636, 10.1038/oby.2008.228 · DOI
  8. Chlebowski, 2002, J. Clin. Oncol., 20, 1128, 10.1200/JCO.20.4.1128 · doi:10.1200/jco.20.4.1128 · Paper page
  9. Berclaz, 2004, Ann. Oncol., 15, 875, 10.1093/annonc/mdh222 · DOI · Paper page
  10. Whiteman, 2005, Cancer Epidemiol. Biomarkers Prev., 14, 2009, 10.1158/1055-9965.EPI-05-0106 · DOI · Paper page
  11. Cleveland, 2005, Cancer Epidemiol. Biomarkers Prev., 16, 1803, 10.1158/1055-9965.EPI-06-0889 · DOI · Paper page
  12. Chang, 1998, J. Clin. Oncol., 6, 3731, 10.1200/JCO.1998.16.12.3731 · DOI
  13. Chang, 2000, Breast Cancer Res. Treat., 64, 157, 10.1023/A:1006489100283 · DOI
  14. Enger, 2007, Arch. Surg., 139, 954, 10.1001/archsurg.139.9.954 · DOI · Paper page
  15. 10.1207/S15327914NC4402_02 · DOI · Paper page
  16. Huang, 1999, Am. J. Epidemiol., 150, 1316, 10.1093/oxfordjournals.aje.a009963 · DOI · Paper page
  17. Olson, 2006, J. Womens Health (Larchmt), 15, 836, 10.1089/jwh.2006.15.836 · DOI
  18. Goodwin, 2009, Breast Cancer Res. Treat., 114, 517, 10.1007/s10549-008-0019-0 · DOI
  19. Borugian, 2003, Am. J. Epidemiol., 158, 963, 10.1093/aje/kwg236 · DOI · Paper page
  20. Maehle, 2004, APMIS, 112, 349, 10.1111/j.1600-0463.2004.apm1120605.x · DOI
  21. Porter, 2006, Ann. Surg. Oncol., 13, 327, 10.1245/ASO.2006.03.049 · DOI
  22. Daling, 2001, Cancer, 92, 720, 10.1002/1097-0142(20010815)92:4<720::AID-CNCR1375>3.0.CO;2-T · DOI · Paper page
  23. Hunt, 2000, AJR Am. J. Roentgenol., 174, 1251, 10.2214/ajr.174.5.1741251 · DOI
  24. Rose, 2001, Cancer Detect. Prev., 25, 16
  25. Rose, 2007, Endocr. Rev., 28, 763, 10.1210/er.2006-0019 · DOI · Paper page
  26. Cui, 2002, J. Womens Health Gend. Based Med., 11, 527, 10.1089/152460902760277886 · DOI
  27. Porter, 2004, Cancer, 100, 2533, 10.1002/cncr.20279 · DOI
  28. Borgquist, 2009, Int. J. Cancer, 124, 402, 10.1002/ijc.23850 · doi:10.1002/ijc.23850
  29. Oestreicher, 2004, Breast Cancer Res. Treat., 85, 133, 10.1023/B:BREA.0000025402.70958.3e · DOI
  30. Gentili, 1981, Cancer, 48, 974, 10.1002/1097-0142(19810815)48:4<974::AID-CNCR2820480420>3.0.CO;2-# · doi:10.1002/1097-0142(19810815)48:4<974::aid-cncr2820480420>3.0.co;2-#
  31. McGurrin, 1987, Cancer, 59, 1744, 10.1002/1097-0142(19870515)59:10<1744::AID-CNCR2820591012>3.0.CO;2-D · DOI
  32. Demirkan, 2007, Jpn. J. Clin. Oncol., 37, 256, 10.1093/jjco/hym023 · DOI
  33. Loi, 2005, Cancer Epidemiol. Biomarkers Prev., 14, 1686, 10.1158/1055-9965.EPI-05-0042 · DOI · Paper page
  34. Silha, 2005, Int. J. Obes. (Lond.), 29, 1308, 10.1038/sj.ijo.0802987 · DOI · Paper page
  35. Dawood, 2008, Clin. Cancer Res., 14, 1718, 10.1158/1078-0432.CCR-07-1479 · DOI · Paper page
  36. Amend, 2006, Cancer Res., 66, 8327, 10.1158/0008-5472.CAN-06-1927 · DOI · Paper page
  37. Rosenberg, 2006, Cancer Epidemiol. Biomarkers Prev., 15, 2482, 10.1158/1055-9965.EPI-06-0489 · DOI · Paper page
  38. Suzuki, 2006, Int. J. Cancer, 119, 1683, 10.1002/ijc.22034 · DOI · Paper page
  39. Colditz, 2004, J. Natl Cancer Inst., 96, 218, 10.1093/jnci/djh025 · DOI · Paper page
  40. Huang, 2000, Am. J. Epidemiol., 151, 703, 10.1093/oxfordjournals.aje.a010265 · DOI · Paper page
  41. Enger, 2000, Cancer Epidemiol. Biomarkers Prev., 9, 681
  42. Suzuki, 2009, Int. J. Cancer, 124, 698, 10.1002/ijc.23943 · DOI · Paper page
  43. Kyndi, 2008, J. Clin. Oncol., 26, 1419, 10.1200/JCO.2007.14.5565 · DOI · Paper page
  44. Gajdos, 2000, J. Am. Coll. Surg., 190, 523, 10.1016/S1072-7515(00)00257-X · DOI · Paper page
  45. Hess, 2003, Breast Cancer Res. Treat., 78, 105, 10.1023/A:1022166517963 · DOI · Paper page
  46. Reis-Filho, 2008, Histopathology, 52, 108, 10.1111/j.1365-2559.2007.02889.x · DOI · Paper page
  47. Haffty, 2006, J. Clin. Oncol., 24, 5652, 10.1200/JCO.2006.06.5664 · DOI · Paper page
  48. Dent, 2008, Breast Cancer Res. Treat., 115, 423, 10.1007/s10549-008-0086-2 · DOI · Paper page
  49. Millikan, 2008, Breast Cancer Res. Treat., 109, 123, 10.1007/s10549-007-9632-6 · DOI · Paper page
  50. Key, 2002, J. Natl Cancer Inst., 94, 606, 10.1093/jnci/94.8.606 · DOI · Paper page
  51. Feigelson, 2004, Cancer Epidemiol. Biomarkers Prev., 13, 220, 10.1158/1055-9965.EPI-03-0301 · DOI · Paper page
  52. De Pergola, 2006, Obesity (Silver Spring), 14, 1954, 10.1038/oby.2006.228 · DOI
  53. Goodwin, 2002, J. Clin. Oncol., 20, 42, 10.1200/JCO.20.1.42 · doi:10.1200/jco.20.1.42 · Paper page
  54. Borugian, 2004, Cancer Epidemiol. Biomarkers Prev., 13, 1163, 10.1158/1055-9965.1163.13.7 · DOI · Paper page
  55. Kerbel, 2008, N. Engl. J. Med., 358, 2039, 10.1056/NEJMra0706596 · DOI · Paper page
  56. Fain, 2005, Metabolism, 54, 220, 10.1016/j.metabol.2004.08.016 · DOI
  57. Bermont, 2001, J. Clin. Endocrinol. Metab., 86, 363
  58. Shrader, 2009, Arch. Dermatol. Res., 301, 159, 10.1007/s00403-008-0921-7 · DOI
  59. Ishikawa, 2004, Clin. Cancer Res., 10, 4325, 10.1158/1078-0432.CCR-03-0749 · DOI · Paper page
  60. Liu, 2007, Oncology, 72, 75, 10.1159/000111097 · doi:10.1159/000111097
  61. Ligibel, 2008, J. Clin. Oncol., 26, 907, 10.1200/JCO.2007.12.7357 · DOI · Paper page
  62. Kroenke, 2005, J. Clin. Oncol., 23, 1370, 10.1200/JCO.2005.01.079 · DOI · Paper page
  63. Griggs, 2005, Arch. Intern. Med., 165, 1267, 10.1001/archinte.165.11.1267 · DOI · Paper page
  64. Dignam, 2003, J. Natl Cancer Inst., 95, 1467, 10.1093/jnci/djg060 · DOI · Paper page
  65. Goodwin, 2008, Clin. Breast Cancer, 8, 501, 10.3816/CBC.2008.n.060 · DOI · Paper page
  66. Chlebowski, 2006, J. Natl Cancer Inst., 98, 1767, 10.1093/jnci/djj494 · DOI · Paper page
  67. Dignam, 2006, Breast Cancer Res. Treat., 97, 245, 10.1007/s10549-005-9118-3 · DOI
  68. Braithwaite, 2009, Int. J. Cancer, 124, 1213, 10.1002/ijc.24054 · DOI

Cited by

Metadata

Authors
Rose, D. P., & Vona-Davis, L.
Venue
Expert Review of Anticancer Therapy
Published
2009-08
Volume
9
Issue
8
Pages
1091-1101
ISSN
  • 1473-7140 (ISSN-L)
  • 1744-8328
OpenAlex
W2020938980
Cited by
71
References
3
FWCI
2.83
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.